Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor

The poor immunotherapy of pancreatic cancer is mainly due to its complex immunosuppressive microenvironment. The Mediterranean diet contributes to low cancer incidence. Hydroxytyrosol (HT) derived from olive oil has multiple health-promoting effects, but its therapeutic effect on pancreatic cancer r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Botao Wang, Lei Yang, Tianyu Liu, Jing Xun, Yuzhen Zhuo, Lanqiu Zhang, Qi Zhang, Ximo Wang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/259294ad69584921bf0709d67c689e9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:259294ad69584921bf0709d67c689e9f
record_format dspace
spelling oai:doaj.org-article:259294ad69584921bf0709d67c689e9f2021-11-11T10:15:31ZHydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor1663-981210.3389/fphar.2021.759172https://doaj.org/article/259294ad69584921bf0709d67c689e9f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.759172/fullhttps://doaj.org/toc/1663-9812The poor immunotherapy of pancreatic cancer is mainly due to its complex immunosuppressive microenvironment. The Mediterranean diet contributes to low cancer incidence. Hydroxytyrosol (HT) derived from olive oil has multiple health-promoting effects, but its therapeutic effect on pancreatic cancer remains controversial. Here, we evaluated the inhibitory effect of HT on mouse pancreatic cancer, and the effect of HT on the immune microenvironment. We found that HT can inhibit the proliferation of Panc 02 cells through signal transducer and activator of transcription (STAT) 3/Cyclin D1 signaling pathway. In the tumor-bearing mice treated with HT, the orthotopic pancreatic tumors were suppressed, accompanied by a decrease in the proportion of myeloid-derived suppressor cells (MDSCs) and an increase in the proportion of M1 macrophages. In addition, we found that HT inhibited the expression of immunosuppressive molecules in bone marrow (BM)-derived MDSCs, as well as down-regulated CCAAT/enhancer-binding protein beta (C/EBPβ) and phosphorylation of STAT3. Moreover, HT enhanced the anti-tumor effect of anti-CD47 antibody in vivo. HT combined with plumbagin (PLB) induced more Panc 02 cells death than HT or PLB alone. This combination therapy not only inhibited the accumulation of MDSCs, but also promoted the infiltration of CD4+ and CD8+ T cells in the tumors. In summary, HT is a potential immunomodulatory drug for the treatment of pancreatic cancer.Botao WangBotao WangLei YangTianyu LiuTianyu LiuJing XunYuzhen ZhuoLanqiu ZhangQi ZhangQi ZhangXimo WangXimo WangXimo WangFrontiers Media S.A.articlehydroxytyrosolpancreatic cancerMDSCsM1 macrophagesstat3Therapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic hydroxytyrosol
pancreatic cancer
MDSCs
M1 macrophages
stat3
Therapeutics. Pharmacology
RM1-950
spellingShingle hydroxytyrosol
pancreatic cancer
MDSCs
M1 macrophages
stat3
Therapeutics. Pharmacology
RM1-950
Botao Wang
Botao Wang
Lei Yang
Tianyu Liu
Tianyu Liu
Jing Xun
Yuzhen Zhuo
Lanqiu Zhang
Qi Zhang
Qi Zhang
Ximo Wang
Ximo Wang
Ximo Wang
Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
description The poor immunotherapy of pancreatic cancer is mainly due to its complex immunosuppressive microenvironment. The Mediterranean diet contributes to low cancer incidence. Hydroxytyrosol (HT) derived from olive oil has multiple health-promoting effects, but its therapeutic effect on pancreatic cancer remains controversial. Here, we evaluated the inhibitory effect of HT on mouse pancreatic cancer, and the effect of HT on the immune microenvironment. We found that HT can inhibit the proliferation of Panc 02 cells through signal transducer and activator of transcription (STAT) 3/Cyclin D1 signaling pathway. In the tumor-bearing mice treated with HT, the orthotopic pancreatic tumors were suppressed, accompanied by a decrease in the proportion of myeloid-derived suppressor cells (MDSCs) and an increase in the proportion of M1 macrophages. In addition, we found that HT inhibited the expression of immunosuppressive molecules in bone marrow (BM)-derived MDSCs, as well as down-regulated CCAAT/enhancer-binding protein beta (C/EBPβ) and phosphorylation of STAT3. Moreover, HT enhanced the anti-tumor effect of anti-CD47 antibody in vivo. HT combined with plumbagin (PLB) induced more Panc 02 cells death than HT or PLB alone. This combination therapy not only inhibited the accumulation of MDSCs, but also promoted the infiltration of CD4+ and CD8+ T cells in the tumors. In summary, HT is a potential immunomodulatory drug for the treatment of pancreatic cancer.
format article
author Botao Wang
Botao Wang
Lei Yang
Tianyu Liu
Tianyu Liu
Jing Xun
Yuzhen Zhuo
Lanqiu Zhang
Qi Zhang
Qi Zhang
Ximo Wang
Ximo Wang
Ximo Wang
author_facet Botao Wang
Botao Wang
Lei Yang
Tianyu Liu
Tianyu Liu
Jing Xun
Yuzhen Zhuo
Lanqiu Zhang
Qi Zhang
Qi Zhang
Ximo Wang
Ximo Wang
Ximo Wang
author_sort Botao Wang
title Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
title_short Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
title_full Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
title_fullStr Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
title_full_unstemmed Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
title_sort hydroxytyrosol inhibits mdscs and promotes m1 macrophages in mice with orthotopic pancreatic tumor
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/259294ad69584921bf0709d67c689e9f
work_keys_str_mv AT botaowang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT botaowang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT leiyang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT tianyuliu hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT tianyuliu hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT jingxun hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT yuzhenzhuo hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT lanqiuzhang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT qizhang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT qizhang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT ximowang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT ximowang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
AT ximowang hydroxytyrosolinhibitsmdscsandpromotesm1macrophagesinmicewithorthotopicpancreatictumor
_version_ 1718439198725242880